CVEO vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CVEO exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating deteriorating financial health. While the stock has seen recent price appreciation, it is fundamentally overvalued with an extreme PEG ratio of 191.60 and a forward P/E of 58.26. Profitability remains negative with an ROE of -9.76% and a consistent track record of missing earnings estimates (0/4 beats in the last year). The current valuation is disconnected from the company's operational performance and poor deterministic health scores.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
CVEO vs TSLA: Head-to-Head Comparison
This page compares Civeo Corporation (CVEO) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.